NERVGEN PHARMA CORP (NGEN) Institutional Ownership and Insiders Activity

NERVGEN PHARMA CORP (NGEN) is widely held by institutional investors, with 64 firms reporting positions valued at approximately $26.58M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Empery Asset Management, Lp is the largest disclosed holder, reporting approximately $8.24M in NGEN holdings in its latest filing.